Pregnancy and Crohn's disease.

Details

Serval ID
serval:BIB_9B417118D447
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Pregnancy and Crohn's disease.
Journal
Digestion
Author(s)
Mottet C., Juillerat P., Gonvers J.J., Froehlich F., Burnand B., Vader J.P., Michetti P., Felley C.
ISSN
0012-2823
Publication state
Published
Issued date
2005
Peer-reviewed
Oui
Volume
71
Number
1
Pages
54-61
Language
english
Notes
Publication types: Journal Article ; Review - Publication Status: ppublish
Abstract
Crohn's disease commonly affects women of childbearing age. Available data on Crohn's disease and pregnancy show that women with Crohn's disease can expect to conceive successfully, carry to term and deliver a healthy baby. Control of disease activity before conception and during pregnancy is critical, to optimize both maternal and fetal health. Generally speaking, pharmacological therapy for Crohn's disease during pregnancy is similar to pharmacological therapy for non-pregnant patients. Patients maintained in remission by way of pharmacological therapy should continue it throughout their pregnancy. Most drugs, including sulfasalazine, mesalazine, corticosteroids, and immunosuppressors such as azathioprine and 6-mercaptopurine, are safe, whereas methotrexate is contraindicated.
Keywords
Animals, Anti-Infective Agents, Anti-Inflammatory Agents, Non-Steroidal, Crohn Disease, Drug Therapy, Combination, Female, Glucocorticoids, Humans, Immunologic Factors, Mesalamine, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Safety
Pubmed
Web of science
Create date
25/01/2008 15:58
Last modification date
20/08/2019 15:02
Usage data